Health Robotics and Grifols Sign Exclusive Cooperation Agreement for the I.V. Room of the Future Initiative

BOZEN, Sud-Tirol, Italy, December 3, 2010 - Health Robotics today announced that it recently signed an exclusive
cooperation agreement for Grifols to significantly contribute to its I.V.
Room of the Future Initiative with its Misterium state-of-the-art Clean Room
products and I.V. Therapy and Clinical Nutrition scientific knowledge and
experience. The agreement also includes the appointment of Grifols'
scientific expert Dr. Oriol Prat as an additional member of Health Robotics'
Scientific Advisory Board, where he will join representatives of The
Cleveland Clinic Foundation, Ochsner Clinic, Sutter Health, USC University
Hospital, and The University of Chicago Medical Center.

"Grifols has designed and constructed more than 1.2 million square feet
of clean rooms worldwide and managed more than 150 modular clean room
installations at hospitals. After witnessing the outstanding combined results
of the joint implementation of Misterium and i.v.STATION at Vall d'Hebron
University Hospital in Barcelona, I was convinced that global hospitals stand
to greatly benefit from the synergies between the respective companies'
experience, products, and services within the I.V. Room Technology sector,"
stated Gaspar DeViedma, Health Robotics' Executive Vice President.

"Among the advantages of Misterium modular clean rooms over conventional
construction include their flexible, convenient and fast construction,
usually within 2 to 4 weeks, with minimal disruption to the pharmacy's
operations, ease of maintenance, GMP compliance, and integrated training
tools and workflow analysis," stated Xavier Guix, Vice President of Marketing
for Grifols' Hospital System Division.

About Grifols S.A.:

Grifols is a Spain-based company engaged in the healthcare sector and is
listed on Ibex-35 stock market. Grifols is involved in the research,
development, manufacturing and marketing of plasma derivates, IV therapy
solutions, enteral and parenteral nutrition, diagnostic systems, pharmacy
automation, and medical materials and devices. Founded in 1940, Grifols
currently operates in 90 countries with more than 6.000 employees, 26
subsidiaries with combined gross revenues over EUR800 million, and a EUR3
billion market capitalization. For more information, please visit
www.grifols.com

About Health Robotics:

Health Robotics is the undisputed global leading supplier of
life-critical intra-venous medication robots, providing healthcare facilities
in 5 continents with robotics technology and software automation solutions
deployed utilizing virtual high-availability technology. Its world-leading
solutions CytoCare(R) [hazardous IVs], i.v.STATION(TM) [non-hazardous IVs],
i.v.SOFT(R) [manual compounding software], MEDarchiver (R) [clinical
information system], and TPNstation(TM) [totally-automated parenteral
nutrition] have and will greatly contribute to ease hospitals' growing
pressures to improve patient safety, increase throughput and contain costs.
Through the effective and efficient production of sterile, accurate,
tamper-evident and ready-to-administer IVs, Health Robotics' solutions help
hospitals eliminate life-threatening drug-exchange errors, decrease other
medical errors and sterility risks, work more efficiently, reduce waste and
controlled substances' diversion, and diminish the gap between rising patient
volume/acuity and scarce medical, nursing, and pharmacy staff. For more
company information, please visit www.health-robotics.com/

    For additional information, please contact:
    Claudia Flaim, Marketing Coordinator
    flaim@health-robotics.com
    Phone: +39-0471-200-372

For additional information, please contact: Claudia Flaim, Marketing Coordinator, flaim at health-robotics.com, Phone: +39-0471-200-372